Documentos de Pandian J.D. | REDI

Regresar

Mostrando 3 resultados de: 3

Filtros aplicados

Palabras Claves: "Hypertension"

Subtipo de publicación

Conference Object(1)

Publisher

International Journal of Stroke(1)

Área temáticas

Enfermedades(2)

Fisiología humana(2)

Ginecología, obstetricia, pediatría, geriatría(2)

Farmacología y terapéutica(1)

Medicina y salud(1)

Área de conocimiento

Medicina interna(3)

Año de Publicación

Origen

Palabras Claves

Acute ischaemic stroke(1)

Blood pressure(1)

Brain Infarction(1)

Associations of Early Systolic Blood Pressure Control and Outcome after Thrombolysis-Eligible Acute Ischemic Stroke: Results from the ENCHANTED Study

Abstract: Background and Purpose: In thrombolysis-eligible patients with acute ischemic stroke, there is uncer

Palabras claves:

Blood pressure, Hypertension, intracranial hemorrhage, Ischemic stroke

Anderson C.S., Arima H., Bath P.M.W., Broderick J.P., Chalmers J., Chen G., Chen X., Delcourt C., Demchuk A.M., Donnan G.A., Durham A.C., Lavados P.M., Lee T.H., Levi C., Lindley R.I., Luca Di Tanna G., Martins S.O., Minhas J.S., Moullaali T.J., Octavio Marques Pontes-Neto, Olavarria V.V., Pandian J.D., Parsons M.W., Ricci S., Robinson T.G., Sato S., Sharma V.K., Silva-Sieger F.A., Song L., Thang N.H., Wang J.G., Wang X., Woodward M.

Low-Versus Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy the ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study)

Conference Object

Abstract: Background and Purpose'Many patients receiving thrombolysis for acute ischemic stroke are on prior a

Palabras claves:

aspirin, Brain Infarction, Hypertension, intracranial hemorrhages, Tissue plasminogen activator

Arima H., Bath P.M.W., Billot L., Broderick J.P., Chalmers J., Demchuk A.M., Donnan G.A., Kim J.S., Lavados P.M., Lee T.H., Lindley R.I., Martins S.O., Nguyen T.H., Octavio Marques Pontes-Neto, Olavarria V.V., Pandian J.D., Parsons M.W., Ricci S., Robinson T.G., S Anderson C., Sato S., Sharma V.K., Wang J.G., Wang X., Woodward M.

Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2×2 quasi-factorial randomized controlled trial of low- vs. standard-dose rt-PA and early intensive vs. guideline-recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment

Abstract: Rationale: Controversy exists over the optimal dose of intravenous (iv) recombinant tissue plasminog

Palabras claves:

Acute ischaemic stroke, Alteplase, Dose, Hypertension, Rt-PA, thrombolysis

Arima H., Bath P.M.W., Broderick J.P., Chalmers J., Chen X., Demchuk A.M., Donnan G.A., Fuentes S., Huang Y., Kim J.S., Lavados P.M., Lee T.H., Levi C., Lindley R.I., Martins S.O., Nguyen T.H., Octavio Marques Pontes-Neto, Olavarria V.V., Pandian J.D., Parsons M.W., Ricci S., Robinson T.G., S Anderson C., Sharma V.K., Silva-Sieger F.A., Stapf C., Wang J.G., Woodward M.